SCHEMBL8285334

SCHEMBL8285334

O=C(CCl)NCCS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20309194 0.84
SCHEMBL8906627 0.82 HDAC3 (0.57)
SCHEMBL5533465 0.82 ALDH1A1 (0.72)
SCHEMBL929676 0.80
SCHEMBL1241798 0.80 HDAC3 (0.59)
SCHEMBL12657392 0.78
SCHEMBL928881 0.78
SCHEMBL11127833 0.77 ALDH1A1 (0.94)
SCHEMBL5830059 0.77 ALDH1A1 (0.83)
SCHEMBL3074569 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120009669-A1 BIFUNCTIONAL COMPOUND WITH MONOSACCHARIDE AND N2S2 LIGAND, AND PREPARATION AND USE THEREOF INSTITUTE OF NUCLEAR ENERGY RESEARCH ATOMIC ENERGY COUNCIL, EXECUTIVE YUAN (TW) 2012-01-12 US disclosed
WO-2005075426-A1 NOVEL DIPEPTIDYL PEPTIDASE IV INHIBITORS; PROCESSES FOR THEIR PREPARATION AND COMPOSITIONS THEREOF GLENMARK PHARMACEUTICALS LTD. (US) 2005-08-18 WO disclosed